PRICE T ROWE ASSOCIATES INC /MD/

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 80255 BALTIMORE, MD

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$245,156,935

+$148,905,060 QoQ

Shares Held

2,514,946

+119.3% QoQ

Ownership

4.50%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 269 holders

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. DNTH ranks #20 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,156,935	2,514,946	+119.3%	Shares	Sole	2026-08-14
2026-03-31	$96,251,875	1,146,948	+86.2%	Shares	Defined	2026-05-15
2025-12-31	$25,386,719	616,033	+185.0%	Shares	Sole	2026-02-17
2025-09-30	$8,504,911	216,135	+1921.5%	Shares	Sole	2025-11-14
2025-06-30	$199,191	10,692	+1.9%	Shares	Defined	2025-08-14
2025-03-31	$190,306	10,491	+10.8%	Shares	Defined	2025-05-14
2024-12-31	$206,402	9,468	+21.1%	Shares	Defined	2025-02-14
2024-09-30	$214,138	7,821	—	Shares	Defined	2024-11-14
2021-06-30 MGTA	—	22,558	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.